Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
All patients provided written informed consent and were able to withdraw consent at any time without compromising their treatment for advanced melanoma
The upper arm is listed as an approved injection site on the DailyMed retatrutide label, but it is difficult to reach and control for self-injection
Tirzepatide activates both GIP and GLP-1 pathways, while semaglutide is a GLP-1 receptor agonist
Eli Lilly priced FOUNDAYO comparably to the WEGOVY pill, with self-pay access starting at $149/month for the lowest dose, eligible commercial insurance patients paying as low as $25/month with savings cards, and Medicare Part D patients expected to access it for $50/month beginning July 1, 2026
By combining the effects of GLP-1 and GIP, it promotes greater weight loss and improved glucose control
US$ 21.59
US$ 28.77
US$ 27.32
US$ 23.97
US$ 26.85
US$ 25.35
